002901.SZ SHZ
Double Medical Technology Inc.
1W: +0.7%
1M: -2.4%
3M: -5.0%
YTD: -16.0%
1Y: -30.4%
3Y: +35.9%
5Y: -35.1%
¥40.86 ($6.09)
+0.30 (+0.74%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$442M
+498.6% ▲
5Y CAGR: +0.4%
Capital Expenditures
$270M
+11.5% ▲
5Y CAGR: -3.3%
Free Cash Flow
$172M
+174.1% ▲
5Y CAGR: +8.4%
Dividends Paid
$118M
-1151.9% ▼
Buybacks
$235M
+0.0% ▲
Net Change in Cash
-$33M
-151.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $615M | $692M | $109M | $59M | $385M |
| Depreciation & Amort. | $50M | $71M | $138M | $112M | $126M |
| Stock-Based Comp. | $0 | $33M | $97M | $0 | $0 |
| Change in Working Capital | -$118M | -$134M | -$195M | -$335M | -$189M |
| Other Non-Cash Items | $8M | $16M | -$8M | $242M | $121M |
| Operating Cash Flow | $556M | $673M | $128M | $74M | $442M |
| — Investing Activities — | |||||
| Capital Expenditures | -$137M | -$235M | -$285M | -$306M | -$270M |
| Acquisitions (Net) | $99K | -$88M | -$271K | $0 | $0 |
| Investment Purchases | -$3.6B | -$7.0B | -$4.5B | -$1.7B | -$1.0B |
| Investment Sales | $3.2B | $6.7B | $5.0B | $1.6B | $1.3B |
| Other Investing | $229M | $181M | -$409M | -$144M | $149M |
| Investing Cash Flow | -$276M | -$397M | -$226M | -$508M | $154M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $49M | $530M | -$206M |
| Stock Repurchased | -$2M | $0 | -$76M | $0 | -$235M |
| Dividends Paid | -$241M | -$324M | -$208M | -$9M | -$118M |
| Other Financing | -$15M | $65M | $491M | -$25M | -$58M |
| Financing Cash Flow | -$256M | -$259M | $245M | $496M | -$617M |
| Net Change in Cash | $11M | $14M | $152M | $63M | -$33M |
| Cash End of Period | $48M | $62M | $214M | $277M | $245M |
| Free Cash Flow | $419M | $438M | -$157M | -$232M | $172M |